Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of Nrf2-xCT/GPx4 axis
When you look into the science and into the papers you can see that theres not really much evidence for road cycling
Meet the new GLP-1RX Plus program
According to Drucker the findings, published in December 2023, provided the first demonstration of 'a GLP-1-brain-immune axis that controls inflammation across the body independent of weight loss, even in peripheral organs devoid of GLP1 receptors.' Drucker's team has not yet identified which particular brain cells interact with GLP-1 (AAAS)
Non-Invasive Peptide Administration Research The development of viable non-injectable delivery formats for peptide compounds is a significant area of pharmaceutical and research interest
In CFS/ME, disruptions in this axis are believed to play a central role in the manifestation of fatigue, cognitive dysfunction, and mood disturbances (Knig et al., 2021)